GHOSH ANIRVAN (Chief Executive Officer) sold 1.2% of their position (1.02K shares) of UNITY BIOTECHNOLOGY, INC. on the open market
Open‑market sale worth $1.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 10/31/2023ACC: 0000950170-23-056849
DirectorOfficer· Chief Executive Officer
Since Mar 2020
-1.02K
Net shares
Net seller
$1.9K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
1.02K disposed
Non-Derivative Transactions1
Common Stock, $0.0001 par value
Direct
Shares
−1.02K
Price / share
$1.90
Trade value
$1.95K
% of position
1.2%
10/30/2023
82.22K→81.20K
Total
Net shares
−1.02K
Net value
-$1.95K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.0001 par value Direct | 10/30/2023 | S · Sale | −1.02K | $1.90 | $1.95K | 1.2% | 82.22K | 81.20K |
| Total | −1.02K | -$1.95K | ||||||
Derivative Transactions0
No derivative transactions reported